StockDuty ← Dashboard Oct 31, 2026 05:17 PM ET
SignalMacro

Healthcare earnings are broad: 96% beat EPS estimates and 70% posted Y/Y earnings growth. For the tape, that keeps the defensive-growth bid alive, with $ABBV the clean test case for whether those beat

96% EPS beat rate and 70% year-over-year earnings growth signal strong healthcare sector performance.

ABBV
$291.31
+1.07%
96% EPS beat rate and 70% year-over-year earnings growth signal strong healthcare sector performance.
96% EPS beat rate and 70% year-over-year earnings growth signal strong healthcare sector performance. — impact context not separately stored; see What changed.
Sources